DC60478 · Updated 27 October 2026
ALC-0366
Product Datasheet
ALC-0366 is the ionizable lipid explicitly listed in the BNT142 RNA-LNP formulation disclosed in US20250009780A1. The patent reports formulation composition, in vivo production of a CLDN6×CD3-binding antibody and bounded preclinical tolerability data.
| CAS No. | Not available |
| Chemical Name | ALC-0366 |
| Synonyms | ALC0366, ALC 0366,ALC366, ALC 366, ALC-366 |
| SMILES | OCCCN(CCCCCCCCCOC(C(CCCC)CCCCCC)=O)CCCCCCCCCOC(C(CCCC)CCCCCC)=O |
| Formula | C45H89NO5 |
| M.Wt | 724.2 |
| Purity | >95% by ELSD-HPLC |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication |
Research evidence
Read detailed Formulation & Performance
Specifications are catalog specifications, not batch test results.